Themis Bioscience's Series B - II Round

Themis Bioscience raised a round of funding on November 28, 2016.

Themis Bioscience develops prophylactic vaccines with a focus on emerging tropical infectious diseases and has initial vaccine candidates currently in development for chikungunya and dengue fever. The…

Articles about Themis Bioscience's Series B - II Round: